Anti-Human IL5RA Recombinant Antibody

Product Information

Catalog Number	YR1226
Product Name	Anti-Human IL5RA Recombinant Antibody
Molecular Name	Benralizumab
Alias	Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab
CAS Number	1044511-01-4
Target	IL5RA[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	WB, FCM, IP, ELISA, Neut, FuncS, IF
Buffer	PBS, pH7.5
Background	Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price